✦ LIBER ✦

Polyomavirus BK-Specific Cellular Immune Response to VP1 and Large T-Antigen in Kidney Transplant Recipients

✍ Scribed by S. Binggeli; A. Egli; S. Schaub; I. Binet; M. Mayr; J. Steiger; H. H. Hirsch

Book ID: 114804332
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 160 KB
Volume: 7
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2007.01754.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antigen-specific T cell responses to BK

Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation

✍ A. Chakera; S. Bennett; S. Lawrence; O. Morteau; P. D. Mason; C. A. O'Callaghan; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Detection of CD8+ T Cells Sensitized to

Detection of CD8+ T Cells Sensitized to BK Virus Large T Antigen in Healthy Volunteers and Kidney Transplant Recipients

✍ Parmjeet S. Randhawa; Iulia Popescu; Camila Macedo; Adriana Zeevi; Ron Shapiro; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB

BKV and JCV large T antigen-specific CD8

BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy

✍ Yiping Chen; Jennifer Trofe; Jennifer Gordon; Patrick Autissier; E. Steve Woodle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Vaccination against hepatitis B in liver

Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells

✍ Tanja Bauer; Matthias Günther; Ulrich Bienzle; Ruth Neuhaus; Wolfgang Jilg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at